Evidence map›Paper›PMID 38253606›Full record

ArticleNature communications2024

Pangenome graphs improve the analysis of structural variants in rare genetic diseases.

Cristian Groza, Carl Schwendinger-Schreck, Warren A Cheung, Emily G Farrow, Isabelle Thiffault, Juniper Lake, William B Rizzo, Gilad Evrony, Tom Curran, Guillaume Bourque and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
18.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Approaches to Studying Viral Pangenome Variation Graphs.Genomics, proteomics & bioinformatics · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Charcot-Marie-Tooth disease and related neuropathies.Nature reviews. Disease primers · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Agptools: a utility suite for editing genome assemblies.Bioinformatics (Oxford, England) · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

Cristian GrozaQuantitative Life Sciences, McGill University, Montréal, QC, Canada.ORCID 0000-0001-6624-5404
Carl Schwendinger-SchreckGenomic Medicine Center, Children's Mercy Hospital and Research Institute, KC, MO, USA.
Warren A CheungGenomic Medicine Center, Children's Mercy Hospital and Research Institute, KC, MO, USA.ORCID 0000-0003-0267-7464
Emily G FarrowGenomic Medicine Center, Children's Mercy Hospital and Research Institute, KC, MO, USA.ORCID 0000-0002-8864-7073
Isabelle ThiffaultGenomic Medicine Center, Children's Mercy Hospital and Research Institute, KC, MO, USA.ORCID 0000-0001-7987-6731
Juniper LakePacific Biosciences, Menlo Park, CA, USA.ORCID 0000-0001-7628-5645
William B RizzoChild Health Research Institute, Department of Pediatrics, Nebraska Medical Center, Omaha, NE, USA.
Gilad EvronyCenter for Human Genetics and Genomics, Department of Pediatrics, Neuroscience & Physiology, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0000-0001-7621-2630
Tom CurranChildren's Mercy Research Institute, Kansas City, MO, USA.ORCID 0000-0003-1444-7551
Guillaume BourqueCanadian Center for Computational Genomics, McGill University, Montréal, QC, Canada. guil.bourque@mcgill.ca.ORCID 0000-0002-3933-9656
Tomi PastinenGenomic Medicine Center, Children's Mercy Hospital and Research Institute, KC, MO, USA. tpastinen@cmh.edu.ORCID 0000-0003-4016-5021
Children's Mercy Hospital · USCenter for Human Genetics · USKyoto University · JPMcGill University · CAMercy Research · USNebraska Medical Center · USPacific Biosciences (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rare DNA alterations that cause heritable diseases are only partially resolvable by clinical next-generation sequencing due to the difficulty of detecting structural variation (SV) in all genomic contexts. Long-read, high fidelity genome sequencing (HiFi-GS) detects SVs with increased sensitivity and enables assembling personal and graph genomes. We leverage standard reference genomes, public assemblies (n = 94) and a large collection of HiFi-GS data from a rare disease program (Genomic Answers for Kids, GA4K, n = 574 assemblies) to build a graph genome representing a unified SV callset in GA4K, identify common variation and prioritize SVs that are more likely to cause genetic disease (MAF < 0.01). Using graphs, we obtain a higher level of reproducibility than the standard reference approach. We observe over 200,000 SV alleles unique to GA4K, including nearly 1000 rare variants that impact coding sequence. With improved specificity for rare SVs, we isolate 30 candidate SVs in phenotypically prioritized genes, including known disease SVs. We isolate a novel diagnostic SV in KMT2E, demonstrating use of personal assemblies coupled with pangenome graphs for rare disease genomics. The community may interrogate our pangenome with additional assemblies to discover new SVs within the allele frequency spectrum relevant to genetic diseases.

Indexed as

GenomicsRare DiseasesAllelesChromosome MappingHumansReproducibility of Results

Identifiers

PMID38253606
PMCPMC10803329
OpenAlexW4391104625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.